CLEAR Claims Life Sciences Life Sciences Download

Clinical Trial Solutions Life Sciences Download

Osteoporosis and low bone mass affect almost 54 million people in the US, placing them at risk for hip, spine, wrist fractures, permanent pain, limited mobility, and increased morbidity and mortality. The disease affects people of all races, ethnicities, and gender, although significant variation within these groups does exist. For the over fifty population, osteoporosis…

Colorectal Cancer Awareness Month is observed in March to highlight the importance of screening for colorectal cancer, as well as to promote healthy lifestyle habits that can decrease a person’s risk of developing cancer of the colon, rectum or anus – the three distinct cancer types referred to as colorectal cancer (CRC). CRC Is the…

Over the last decade, the life sciences industry has used digital advertising at an increasing rate to engage with patients throughout the drug development life cycle. From creating disease state awareness, to driving drug adherence, the trend particularly accelerated during 2020 and 2021, as pharmaceutical brands looked for ways to stay engaged with their patients…

Although biologics and biosimilar drugs only represent 2% of U.S. prescription volume, these naturally sourced medications have recently become the focus of much discussion across healthcare channels. Biologics – often considered specialty drugs – have accounted for as much as 37% of drug spending in a single year.

While only half as many are diagnosed, researchers estimate that hypothyroidism affects as much as 10% of the general population. Also known as “underactive thyroid,” this condition is characterized by a thyroid gland that doesn’t produce enough thyroid hormone (TH).

To create a market assessment, more and more brand strategists are moving towards the use of RWD and RWE. In this blog, we walk through a hypothetical example – sizing the market for Hemophilia A – doing just that.  Creating a market assessment is a critical step in commercializing a new drug. This is because…

Developing, testing and getting approval for a new drug is a tough feat – but only half the battle. Now that your new drug is ready to be commercialized, you have to get it to the right patients, which starts with finding the right physicians. Here’s how this process works – and how to use…